Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Policy topic
No spam. Unsubscribe anytime.
Utah House approves mammography notification bill after contentious debate over medical guidance and patient anxiety
Summary
The House approved first-substitute House Bill 258 to require standardized mammography notification language about dense breast tissue; supporters said the change gives patients information, while doctors warned the statutory language may prompt unnecessary follow-up testing, anxiety and legal standards of care.
First substitute House Bill 258, presented by Representative Christiansen, would require mammography providers to include language notifying patients when their mammogram indicates dense breast tissue and to describe that density can make cancers harder to detect by mammography and that patients "might benefit from additional screening options." The sponsor said the language is modeled on statutes in other states (notably Arizona) and is intended to inform patients so they can discuss options with a clinician.
Supporters and many patient advocates described the change as an information-rights measure. The sponsor told the House that many women have asked for explicit notification and that the intent is to give patients context for their mammography report so they can make informed decisions with their health care provider.
Physicians and some members expressed strong concerns. Representative Kennedy declared a conflict of interest and said plainly, "This bill is great for my business," arguing the statutory notice will generate additional tests, create patient anxiety and could create expectations that physicians must order follow-up imaging to avoid malpractice exposure. Representative Kennedy and other medical members cautioned that routinely prompting additional imaging may produce limited mortality benefit, added costs and uneven access for patients who cannot afford follow-up diagnostic tests.
Other members and many patient advocates urged the House to provide patients this information and noted that 31 other states have notification laws or guidance on breast density language. Sponsors said the bill's phrasing intentionally does not mandate follow-up tests but rather informs patients and asks them to consult clinicians about options.
The House ultimately recorded passage of the first substitute (vote reported on the floor as passage, with a final floor statement that it "having received 39" and passed the House); the transcript records a lengthy and emotionally charged floor debate that balanced patient information rights, clinical uncertainty and concerns about downstream costs and access.
